Overall, in late-stage MPN, a PD-1:PD-L1 blockade may be hampered by the general deregulation and exhaustion of the immune system (4), which is characterized by a down-regulation of HLA molecules and severe gene dysregulation of proteins involved in inflammation (42, 43). This evidence concerns the gene CD274 and myeloproliferative neoplasm.